CAN-2409 plus valacyclovir significantly improved disease-free survival compared with placebo plus valacyclovir. Phase 3 data from the PrTK03 trial (NCT01436968) were recently presented at the ...

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Joy Maulik, CRNP, speaks with J. Brandon Arruda, APRN, AGNP-C, CUNP, about the evolving role of advanced practice providers in urology. In this episode of The Expert Approach: Conversations in ...

The Expert APProach: Conversations in Uro-Oncology, hosted by Joy Maulik, CRNP, is the latest multimedia program from Urology Times. In this debut episode of The Expert APProach: Conversations in ...

Melvin L.K. Chua, FRCR, PhD, FASCO, highlights data validating the performance of the ArteraAI Prostate test in an Asian cohort of patients with prostate cancer. Data presented at the American Society ...

Zenflow's Spring Scope, a single-use cystoscope, received FDA 510(k) clearance, featuring a 12 French working channel for improved visualization. The Zenflow Spring System showed a 46% improvement in ...

Johnson & Johnson's gemcitabine intravesical system approved for BCG-unresponsive NMIBC, showing an 82% complete response rate in the SunRISe-1 trial. Medtronic's Altaviva device approved for urge ...

Mitomycin for intravesical solution shows robust efficacy in treating recurrent LG-IR-NMIBC, with high complete response rates across multiple clinical trials. The treatment offers a non-surgical ...

PAM50 gene expression signature identifies prostate cancer patients who benefit from hormone therapy post-radical prostatectomy. Luminal B tumors showed significant improvement in bPFS and MFS with ...

Krambeck pointed to the growing importance of medical management in stone disease prevention. In this video, Amy E. Krambeck, MD, a professor of urology at the Northwestern University Feinberg School ...

Daniel Spratt, MD, presented data validating the PAM50 gene expression signature as the first predictive biomarker to guide hormone therapy in prostate cancer. According to the authors, CAN-2409 may ...

Melvin L.K. Chua, FRCR, PhD, FASCO, highlights data validating the performance of the ArteraAI Prostate test in an Asian cohort of patients with prostate cancer.